Norqay
Technology, a company with more that 30 years experience in organo
metallic precursors for ALD and CVD has just been acquired by MPD
Chemicals. Please find press release below.
TREVOSE, Pa., Jan. 11, 2018 /PRNewswire/ — MPD Chemicals
(MPD), a US-based manufacturer of specialty chemicals and custom
synthesis solutions, announced today the expansion of its manufacturing
capabilities, product portfolio and customer base with the acquisition
of Norquay Technology, Inc.
(Norquay). Located in Chester Pennsylvania, Norquay is the fourth
acquisition to be integrated into the MPD Holdings platform, an Addison Capital portfolio company; existing MPD businesses include Monomer Polymer & Dajac Labs, Silar, and IsoSciences.
Norquay is a specialty chemical manufacturer with over 30 years of expertise in providing the scale-up and production of advanced proprietary custom materials, including organometallic, inorganic and organic molecules. Norquay’s product line includes chromic, electronic, catalyst, ligand, medical adhesive and UV performance products, with a customer base that ranges from startups to large multi-national corporations.
Norquay is a specialty chemical manufacturer with over 30 years of expertise in providing the scale-up and production of advanced proprietary custom materials, including organometallic, inorganic and organic molecules. Norquay’s product line includes chromic, electronic, catalyst, ligand, medical adhesive and UV performance products, with a customer base that ranges from startups to large multi-national corporations.
